New Type of Compounds Prove Their Bacteria-Killing Ability in Animal Model
NEW YORK -- A new kind of bacteria-killing compounds, being called nubiotics, may prove to be potent antimicrobial agents in animal experiments, researchers are reporting in the August 2004 issue of the journal Antimicrobial Agents and Chemotherapy.
Nubiotics are based on nucleic acid and have shown strong activity against a variety of bacteria in the lab dish. They are believed to be completely different from conventional antibiotics, the researchers say, and could offer a new approach to treating burn and wound infections.
Dr. Roderic M. Dale of Oregon-based Oligos Etc., Inc. is the developer of these new compounds. Dale's team evaluated the efficacy of 12 different nubiotics in mice with burn wounds infected with a highly pathogenic strain of the bacterium, Pseudomonas aeruginosa. Four of the nubiotics proved "extremely efficacious," with 60 percent to 100 percent of treated mice surviving, compared with none of the untreated mice. These nubiotics were effective when given either by injection or when applied directly to the wound, the investigators found, resulting in nearly complete eradication of Pseudomonas from the spleen, liver, and blood. In fact, they proved as effective as intravenous administration of ciprofloxacin, a broad-spectrum antibiotic.
Source: Antimicrobial Agents and Chemotherapy
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.
